Results 181 to 190 of about 81,432 (269)

Association of Three HIF‐1α Genotypes With Susceptibility and Severity of Chronic Kidney Disease

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Hypoxic signaling is a critical factor in the pathogenesis of Chronic Kidney Disease (CKD). Hypoxia‐Inducible Factor 1 (HIF‐1) is a transcription factor that is highly expressed in the kidney and is associated with renal tubular hypoxic adaptation. Variation in the HIF‐1α subunit gene has been associated with renal pathologies.
Hanifa Aktar, Shahrzad Ashena, Mohammad Sanaei Ardekani, Shahrzad Movafagh   +3 more
wiley   +1 more source

Absence of Interaction Between 5α‐Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9543-9551, October 2026.
ABSTRACT Aims People with Type 2 diabetes experience higher cardiometabolic risk, and both synthetic glucocorticoids and use of 5α‐reductase inhibitors have been individually linked to increased risk of myocardial infarction. We tested whether the increase in risk is exacerbated by co‐prescription of both drugs.
Haolan Tu, Chengsheng Ju, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Scottish Diabetes Research Network Epidemiology Group, Peter Hanlon, Robert Lindsay, David McAllister, John Petrie, Naveed Sattar, Brian Kennon, Sam Philip, Scott Cunningham, Huan Wang, William Berthon, Helen Colhoun, Paul McKeigue, Sarah Wild, Ewan R. Pearson, Li Wei, Ruth Andrew   +20 more
wiley   +1 more source

Lymphocyte signal transduction defects in cutaneous sarcoidosis and implications for treatment. [PDF]

Front Immunol
Lunt J, Shidhaye A, Fasana C, Morgan M, Schmidt WM, Lee DL, Chen S, McCain KE, Schammel C, Fiester SE, Arce S, Grier JT.   +11 more
europepmc   +1 more source

Serum GFAP and Age Accurately Distinguish AQP4‐IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack

European Journal of Neurology, Volume 33, Issue 10, October 2026.
After a recent NMOSD attack, serum GFAP and age together provide a simple and powerful way to distinguish AQP4‐IgG NMOSD from MOGAD and related disorders. In 240 patients evaluated within 90 days of an attack from a 640‐patient cohort, this combination achieved high diagnostic accuracy (AUC up to 0.95).
Manon Rival, Fabien Rollot, Sabine Laurent‐Chabalier, Romain Casey, Illiasse El Bahi, Guillaume Brocard, Romain Marignier, Sophie Trouillet‐Assant, Sandra Vukusic, Agnès Fromont, David Axel Laplaud, Guillaume Mathey, Elisabeth Maillart, Laure Michel, Aurélie Ruet, Pierre Labauge, Xavier Ayrignac, Hélène Zephir, Jonathan Ciron, Jérôme de Sèze, Arnaud Kwiatkowski, Caroline Papeix, Pierre Branger, Christine Lebrun‐Frenay, Eric Berger, Pierre Clavelou, Olivier Heinzlef, Jean Pelletier, Abdullatif Al‐Khedr, Olivier Casez, Bertrand Bourre, Alain Créange, Thomas David, Laurent Magy, Jean‐Philippe Camdessanche, Inès Doghri, Amélie Dos Santos, Thibault Mura, Hanane Agherbi, Eric Thouvenot, for the OFSEP Group and NOMADMUS Investigators, Nicolas Collongues, Céline Cognet, Mireille Desille‐Dugast, Nathalie Dufay, Mathilde Berthome, Michael Hisbergues, Sylvain Lehmann, Laurence Liang, Céline Loiseau, Julie Marechal, Estelle Nisse, Françoise Durand‐Dubief, François Cotton, Bertrand Audoin, Mikael Cohen, Nicolas Collongues, Romain Deschamps   +57 more
wiley   +1 more source

Infliximab Monotherapy as First-Line Treatment for Hepatic, Splenic, and Pulmonary Sarcoidosis in a Patient With High Cardiometabolic Risk. [PDF]

Cureus
Coimbra M, Saca C, Carvalho MC, Neves M, Delgado Alves J.   +4 more
europepmc   +1 more source

Response to Letter to the Editor. [PDF]

Liver Int
Shani U, Ben-Shabat N.
europepmc   +1 more source

High prevalence of coxsackievirus B antibodies in patients with cardiac sarcoidosis: a retrospective cohort study. [PDF]

Open Heart
Donnelly KL, Wilmoth J, Osborne W, Heavens J, Haworth S, Pandya S, Dalia T, Hamblin M.   +7 more
europepmc   +1 more source

Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: A randomized controlled trial. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Yıldız Ş, Kavas M, Takinaci ZD, Aydoğan Eroğlu S.   +3 more
europepmc   +1 more source

The Efficacy of Different Treatment Options in Cutaneous Sarcoidosis: A Meta-analysis of RCTs. [PDF]

Acta Derm Venereol
Thianich FC, Wörgötter KM, Bruckner L, Grübler MR, Posch C.   +4 more
europepmc   +1 more source

Cirrhosis Risk in Sarcoidosis Without Documented Hepatic Involvement-A Large Nationwide Population-Based Cohort Study. [PDF]

Liver Int
Shani U, Davidov Y, Zigmond E, Ben-Ami T, Regev O, Cohen AD, Amital H, Ben-Shabat N.   +7 more
europepmc   +1 more source